Point72 Asset Management, L.P. 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:46 pm Sale |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
Point72 Asset Management, L.P. | 1,520,007 3.600% |
-1,049,819 (-40.85%) |
Filing |
| 2024-06-24 4:51 pm Purchase |
2024-06-14 | 13G | UroGen Pharma Ltd. URGN |
Point72 Asset Management, L.P. | 2,569,826 6.200% |
2,569,826 (New Position) |
Filing |